This inventor holds 1 USPTO granted patent. Top assignee: Ivax Drug Research Institute. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Gizella Ábrahám: Innovator in Pharmaceutical Chemistry
Introduction
Gizella Ábrahám is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on benzodiazepine derivatives. Her research focuses on developing new compounds that can address various medical conditions.
Latest Patents
Gizella holds a patent for "Substituted 2,3-benzodiazepine derivatives." This invention relates to new 2,3-benzodiazepine derivatives of formula (I), including isomers and acid addition salts. The pharmaceutical compositions derived from her work are designed to treat conditions associated with muscle spasms, epilepsy, and neurodegenerative diseases. Additionally, her inventions aim to alleviate symptoms of acute and chronic inflammatory disorders.
Career Highlights
Gizella Ábrahám has established herself as a key figure in her field, working at the Ivax Drug Research Institute. Her dedication to research and development has led to advancements in pharmaceutical applications that benefit patients worldwide.
Collaborations
Throughout her career, Gizella has collaborated with notable colleagues, including Sándor Sólyom and Tamás Hámori. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Gizella Ábrahám's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. Her work continues to pave the way for new treatments and therapies that address critical medical needs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile